Zantac

Zantac is the trade name for the drug ranitidine, which belongs to the group of H2-histamine receptor blockers.

Ranitidine is used for the treatment and prevention of gastric and duodenal ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome and other diseases accompanied by high stomach acidity.

The mechanism of action of ranitidine is the competitive inhibition of H2-histamine receptors of gastric parietal cells, which leads to suppression of hydrochloric acid secretion.

The drug is available in the form of tablets, injection solution and syrup.

Zantac (ranitidine) is well tolerated and rarely causes side effects. The most common adverse reactions are headache, dizziness, and fatigue.

Zantac is a drug used to treat stomach and duodenal ulcers and to prevent peptic ulcers. It contains ranitidine, a substance that blocks the action of stomach acid on the walls of the stomach, which prevents the development of ulcers and erosions.

Ranitidine was first synthesized in the 1970s and has since become one of the most popular drugs for the treatment of peptic ulcers. Its effectiveness has been proven in numerous studies, which have shown that it reduces the frequency and severity of ulcer bleeding and also prevents the development of new ulcers.

However, like any other drug, Zantac has its side effects. Some can be serious, such as allergic reactions, headache, nausea and vomiting. Sleep disturbances, dizziness and depression are also possible.

In addition, Zantac may interact with other medications, so you should consult your doctor before starting treatment. Overall, Zantac is an effective and safe drug that helps many people cope with peptic ulcers.